当前位置:首页 - 行情中心 - 盘龙药业(002864) - 财务分析 - 现金流量表

盘龙药业

(002864)

  

流通市值:21.05亿  总市值:29.19亿
流通股本:9859.67万   总股本:1.37亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金522,959,977.36255,534,039.481,166,591,896.84865,685,539.67
  收到其他与经营活动有关的现金23,370,420.5313,243,428.2544,706,507.5141,905,712.01
  经营活动现金流入小计546,330,397.89268,777,467.731,211,298,404.35907,591,251.68
  购买商品、接受劳务支付的现金171,434,481.9577,862,469.52546,250,236.9400,936,932.86
  支付给职工以及为职工支付的现金43,464,604.9620,423,075.7389,877,457.6563,973,419.94
  支付的各项税费60,667,369.1931,421,325.1499,627,106.9976,187,507.46
  支付其他与经营活动有关的现金94,242,299.0746,064,760.47412,532,987.62277,337,443.09
  经营活动现金流出小计369,808,755.17175,771,630.861,148,287,789.16818,435,303.35
  经营活动产生的现金流量净额176,521,642.7293,005,836.8763,010,615.1989,155,948.33
二、投资活动产生的现金流量:
  处置固定资产、无形资产和其他长期资产收回的现金净额221,491.37254.95283,416.56283,204.17
  投资活动现金流入小计221,491.37254.95283,416.56283,204.17
  购建固定资产、无形资产和其他长期资产支付的现金17,729,028.528,790,817.0942,405,951.7848,091,241.43
  投资活动现金流出小计17,729,028.528,790,817.0942,405,951.7848,091,241.43
  投资活动产生的现金流量净额-17,507,537.15-8,790,562.14-42,122,535.22-47,808,037.26
三、筹资活动产生的现金流量:
  吸收投资收到的现金5,811,660-1,500,000-
  其中:子公司吸收少数股东投资收到的现金--1,500,000-
  取得借款收到的现金150,000,000150,000,00050,000,00050,000,000
  筹资活动现金流入小计155,811,660150,000,00051,500,00050,000,000
  偿还债务支付的现金197,500,00098,500,000101,000,00051,000,000
  分配股利、利润或偿付利息支付的现金1,062,369.73487,011.9543,894,068.3244,114,966.79
  支付其他与筹资活动有关的现金14,147,584-1,978,467.84978,467.84
  筹资活动现金流出小计212,709,953.7398,987,011.95146,872,536.1696,093,434.63
  筹资活动产生的现金流量净额-56,898,293.7351,012,988.05-95,372,536.16-46,093,434.63
五、现金及现金等价物净增加额102,115,811.84135,228,262.78-74,484,456.19-4,745,523.56
  加:期初现金及现金等价物余额1,094,890,732.971,094,890,732.971,169,375,189.161,169,375,189.16
  期末现金及现金等价物余额1,197,006,544.811,230,118,995.751,094,890,732.971,164,629,665.6
补充资料:
  净利润42,305,825.32-96,021,548.69-
  资产减值准备4,100,067.67-24,453,911.22-
  固定资产和投资性房地产折旧19,459,839.06-34,948,534.8-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧19,459,839.06-34,948,534.8-
  无形资产摊销744,015.58-1,464,699.44-
  长期待摊费用摊销279,062.31-556,257.35-
  处置固定资产、无形资产和其他长期资产的损失262,799.82--129,512.89-
  固定资产报废损失105.28-12,118.47-
  财务费用1,101,253.98-2,184,131.7-
  投资损失110,154.93-133,892.42-
  递延所得税-10,286,072.33--4,442,517.21-
  其中:递延所得税资产减少-9,640,241.3--5,692,266.05-
    递延所得税负债增加-645,831.03-1,249,748.84-
  存货的减少631,574.63--15,405,027.49-
  经营性应收项目的减少71,979,296.96--121,287,180.44-
  经营性应付项目的增加45,534,213.55-46,854,901.96-
  其他299,505.96--2,757,734.79-
  现金的期末余额1,197,006,544.81-1,094,890,732.97-
  减:现金的期初余额1,094,890,732.97-1,169,375,189.16-
  现金及现金等价物的净增加额102,115,811.84--74,484,456.19-
公告日期2026-08-282026-04-282026-04-282025-10-28
审计意见(境内)标准无保留意见
TOP↑